Please assess the completion status of the following clinical trial:

Trial Title: Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of noninfectious uveitis~* diagnosis of macular edema associated with noninfectious uveitis~Exclusion Criteria:~* any ocular trauma within the immediate 6 months prior to treatment~* any photocoagulation or cryotherapy in the 6 months prior to treatment~* any IVT injection of anti-VEGF treatment in the 2 months prior to treatment~* any eye diseases other than uveitis and ME that could compromise central visual acuity~* any previous suprachoroidal injection of triamcinolone acetonide in the study eye

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 4 mg CLS-TA (Type: EXPERIMENTAL): Single unilateral, suprachoroidal injection of 40 mg/mL (4 mg in 100 µL) of CLS-TA
- 0.8 mg CLS-TA (Type: EXPERIMENTAL): Single unilateral, suprachoroidal injection of 8 mg/mL (0.8 mg in 100 µL) of CLS-TA

Based on this trial design, predict the completion outcome and termination type (if applicable).